The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis, Alzheimer's disease, traumatic brain injury, peripheral nerve injury, diabetic neuropathy, lysosomal disease, Parkinson's disease, Huntington's disease, and cerebral palsy.
http://ift.tt/19BGeDy
http://ift.tt/19BGeDy
No comments:
Post a Comment